Log In
BCIQ
Print this Print this
 

CFTR MASTR Dx

  Manage Alerts
Collapse Summary General Information
Company Sophia Genetics S.A.
DescriptionAssay to identify all CFTR variants in individuals with increased risk for cystic fibrosis
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationPulmonary, Diagnostic
Indication DetailsAssay for identification of sequence variants covering the complete CFTR gene in individuals with increased risk for CF
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today